Danielle Gold, an associate attorney in Weitz & Luxenberg’s Drug and Medical Device Litigation group, will participate in a discussion on Stryker’s LFIT V40 hip replacement litigation at the American Association of Justice’s “Hot Topics in Mass Torts” seminar on May 24. She joins a distinguished faculty of leading plaintiff attorneys who will be sharing their expertise and experience, including trial strategies and techniques, in several high profile mass torts.

“The American Association of Justice’s hot topics seminar presents a great opportunity to the mass torts community to discuss key aspects of this new litigation and learn from each other’s respective efforts,” said Ms. Gold. “I am honored to be included in this year’s distinguished faculty and I look forward to being a part of this important conversation.”

Ms. Gold is part of the team at Weitz & Luxenberg representing patients with defective Stryker LFIT V40 implants. In April 2017, federally filed cases received a Multidistrict Litigation designation and were transferred to the District of Massachusetts. The team also has several ongoing cases filed in New Jersey state court. In 2016, Stryker issued a recall for certain LFIT V40 implants, and patients with these devices are at risk for loss of mobility, pain, adverse local tissue reaction, and catastrophic dissociation, all resulting in the need for revision surgery. In November 2014, Weitz & Luxenberg helped secure a $1 billion settlement with Stryker related to defects in its Rejuvenate and ABGII modular hip implants.

Prior to joining Weitz & Luxenberg, Ms. Gold clerked for the Hon. Carol E. Higbee of Superior Court in Atlantic City, one of New Jersey’s three mass tort judges at that time. Super Lawyers magazine has recognized Ms. Gold as a Rising Star in New York.

The “Hot Topics in Mass Torts” event will be held on May 23 and 24 at the Omni Mokara Hotel & Spa in San Antonio.

Get the Help You Need Today

Free Case Review